Peptide Microarray Profiling Identifies Phospholipase C Gamma 1 (Plc-Gamma 1) As A Potential Target For T(8;21) Aml

The t(8;21) (q22;q22) chromosomal translocation is one of the most frequent genetic alterations in acute myeloid leukemia (AML) which has a need for improved therapeutic strategies. We found PLC-gamma 1 as one of the highest phosphorylated peptides in t(8;21) AML samples compared to NBM or CN-AML in our previous peptide microarray. PLC-gamma 1 is known to play a role in cancer progression, however, the impact of PLC-gamma 1 in AML is currently unknown. Therefore, we aimed to study the functional role of PLC-gamma 1 by investigating the cellular growth, survival and its underlying mechanism in t(8;21) AML.In this study, PLC-gamma 1 expression was significantly higher in t(8;21) AML compared to other karyotypes. The PLC-gamma 1 protein expression was suppressed in AML1-ETO knock down cells indicating that it might induce kasumi-1 cell death. ShRNA-mediated PLC-gamma 1 knockdown in kasumi-1 cells significantly blocked cell growth, induced apoptosis and cell cycle arrest which was explained by the increased activation of apoptotic related and cell cycle regulatory protein expressions. Gene expression array analysis showed the up-regulation of apoptotic and DNA damage response genes together with the downregulation of cell growth, proliferation and differentiation genes in the PLC-gamma 1 suppressed kasumi-1 cells, consistent with the observed phenotypic effects. Importantly, PLC-gamma 1 suppressed kasumi-1 cells showed higher chemosensitivity to the chemotherapeutic drug treatments and lower cell proliferation upon hypoxic stress.Taken together, these in vitro finding strongly support an important role for PLC-gamma 1 in the survival of t(8;21) AML mimicking kasumi-1 cells and identify PLC-gamma 1 as a potential therapeutic target for t(8;21) AML treatment.